FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA
Center | Date | Time | Location |
---|---|---|---|
CDRH | May 23, 2006 | 9:30 a.m. - 4:30 p.m. | Holiday Inn |
Agenda:
The committee will hear a presentation explaining FDA's Critical Path Initiative
and a presentation by the Office of Surveillance and Biometrics in the Center
for Devices and Radiological Health outlining their responsibility for the review
of postmarket study design. Subsequently, FDA will present key points for the
committee to consider for the reclassification of full field digital mammography
(FFDM) systems from Class III to Class II devices. The committee will discuss
and make recommendations on the reclassification of FFDMs.
Background material and meeting information will become available no later than one business day before the meeting (Simply scroll down to the appropriate committee heading).
Closed Committee Deliberations:
On May 23, 2006, from 9:30 a.m. to 10:00 a.m., the meeting will be closed to
permit discussion and review of trade secret and/or confidential information
(5 U.S.C. 552b(c)(4)) on current and pending issues regarding radiological devices.
Procedure:
On May 23, 2006, from 10:00 a.m. to 4:30 p.m., the meeting is open to the public.
Interested persons may present data, information, or views, orally or in writing,
on issues pending before the committee. Written submissions may be made to the
contact person by May 9, 2006. Oral presentations from the public will be scheduled
between approximately 11:45 a.m. and 12:45 p.m. Time allotted for each presentation
may be limited. Those desiring to make formal oral presentations should notify
the contact person before May 9, 2006. and submit a brief statement of the general
nature of the evidence or arguments they wish to present, the names and addresses
of proposed participants, and an indication of the approximate time requested
to make their presentation. Persons attending FDA's advisory committee meetings
are advised that the agency is not responsible for providing access to electrical
outlets.
FDA welcomes the attendance of the public at its advisory committee meetings
and will make every effort to accommodate persons with physical disabilities
or special needs. If you require special accommodations due to a disability,
please contact contact AnnMarie Williams, Conference Management Staff, at 240-276-0450,
ext. 113 at least 7 days in advance of the meeting.
Contact Person:
Nancy Wersto, Center for Devices and Radiological Health (HFZ-470), Food and
Drug Administration, 9200 Corporate Blvd., Rockville, MD 20850, 301-594-1212,
ext. 144.
Advisory Committee Telephone Information Line:
Please call the Information Line for up-to-date information on this
meeting, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014512526.